Hoth Therapeutics back in line with Nasdaq minimum bid rule

Rhea-AI Filing Summary

Hoth Therapeutics, Inc. ("HOTH") reported that, on June 18, 2025, The Nasdaq Stock Market notified the company that its common stock satisfied the minimum bid price requirement of $1.00 per share for at least ten consecutive business days, thereby restoring full compliance with Nasdaq Listing Rule 5550(a)(2). The company disclosed the notification in this Form 8-K and simultaneously issued a press release, furnished as Exhibit 99.1.

Positive

• Nasdaq compliance restored: HOTH’s common stock maintained a closing bid of at least $1.00 for 10 consecutive business days, satisfying Listing Rule 5550(a)(2).

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Compliance regained; delisting threat lifted, modest but positive signal.

The Form 8-K solely addresses Nasdaq’s confirmation that HOTH met the $1.00 bid price threshold for ten consecutive sessions, restoring compliance with Rule 5550(a)(2). While this event does not alter the firm’s fundamentals, it eliminates the immediate listing deficiency, preserves market liquidity available through Nasdaq Capital Market, and avoids potential investor concerns tied to delisting proceedings. Because the information deals strictly with maintenance of listing standards and lacks new operational or financial data, its impact is classified as limited yet directionally positive for shareholders.

Portfolio Manager

TL;DR: Positive housekeeping event; no earnings impact, but maintains exchange visibility.

Nasdaq’s compliance notice removes overhang related to bid-price deficiency and ensures uninterrupted trading on a national exchange. Although there are no revenue or profitability implications, uninterrupted Nasdaq listing supports liquidity, analyst coverage, and institutional ownership thresholds. Consequently, I view the announcement as impactful from a governance and capital-market access perspective, yet not material enough to alter valuation models.

false 0001711786 0001711786 2025-06-18 2025-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 18, 2025

Hoth Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-38803		82-1553794
(State or other jurisdiction of incorporation)		(Commission File Number)		(I. R. S. Employer Identification No.)

1177 Avenue of the Americas, 5th Floor, Suite 066

New York, NY 10036

(Address of principal executive offices, including ZIP code)

(646) 756-2997

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.0001 par value		HOTH		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Item 8.01 Other Events.

On June 18, 2025, Hoth Therapeutics, Inc. (the “Company”) received a letter from The Nasdaq Stock Market, LLC (“Nasdaq”) stating that because the Company’s common stock had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2).

On June 18, 2025, the Company issued a press release announcing that it has regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press Release of Hoth Therapeutics, Inc. dated June 18, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

- 1 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 20, 2025	Hoth Therapeutics, Inc.
	/s/ Robb Knie
	Robb Knie
	Chief Executive Officer

- 2 -

FAQ

Why did HOTH file an 8-K on 18 June 2025?

To disclose Nasdaq’s notice that the company had regained compliance with the $1.00 minimum bid price rule.

What Nasdaq rule did Hoth Therapeutics satisfy?

Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.

How was compliance achieved?

HOTH’s common stock closed at or above $1.00 for 10 consecutive business days.

Is there any new financial information in this 8-K?

No. The filing only addresses Nasdaq listing compliance and includes a related press release as Exhibit 99.1.

What trading symbol and exchange apply to Hoth Therapeutics?

The company’s common stock trades on Nasdaq Capital Market under the symbol HOTH.